Company Filing History:
Years Active: 2018-2023
Title: Tomoyuki Koda: Innovator in Pharmaceutical Chemistry
Introduction
Tomoyuki Koda is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic potential. With a total of 5 patents to his name, Koda's work is recognized for its impact on medical science.
Latest Patents
One of Koda's latest patents involves a Dihydroindolizinone derivative, which is a compound represented by a specific general formula. This compound acts as a potent FXIa inhibitor and exhibits excellent oral absorption properties and kinetics in blood. It is capable of exerting a strong anti-coagulation activity over an extended period after oral administration. Notably, there is a discrepancy between its anti-coagulation activity and its CYP-inhibiting activity. This makes the compound or its derivatives suitable for use as an efficient prophylactic and/or therapeutic agent for vascular occlusive diseases.
Career Highlights
Koda is currently associated with Ono Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work has been instrumental in creating innovative solutions for complex medical challenges.
Collaborations
Koda collaborates with notable colleagues, including Motoyuki Tanaka and Takashi Kondo. Their combined expertise enhances the research environment and fosters innovation within their projects.
Conclusion
Tomoyuki Koda's contributions to pharmaceutical chemistry exemplify the spirit of innovation in the medical field. His work on Dihydroindolizinone derivatives showcases the potential for new therapeutic agents that can significantly improve patient outcomes.